Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Translational Medicine|April 5, 2023
Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basisWentao Tian, Xianjing Chu, Guilong Tanzhu, et al.
Frontiers in Oncology|March 3, 2022
Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma PatientsGuilong Tanzhu, Na Li, Zhanzhan Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 26, 2023
CircRNAs and lung cancer: Insight into their roles in metastasisJiaoyang Ning, Yi Luo, Liu Chen, et al.
Acta Neuropathologica Communications|November 27, 2024
An immune scoring system predicts prognosis and immune characteristics in lung adenocarcinoma brain metastases by RNA sequencingGang Xiao, Guilong Tanzhu, Xuan Gao, et al.
Brain Stimulation|July 29, 2025
Tumor treating fields combined with ionizing radiation inhibit the malignant phenotype of lung cancer brain metastasis cells by suppressing DNA damage repair pathwaysGuilong Tanzhu, Haiqin Peng, Liu Chen, et al.
Cell Death Discovery|October 11, 2022
The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapyGuilong Tanzhu, Liu Chen, Gang Xiao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 11, 2023
The protein arginine methyltransferase family (PRMTs) regulates metastases in various tumors: From experimental study to clinical applicationJiaoyang Ning, Liu Chen, Gang Xiao, et al.
Frontiers in Immunology|October 12, 2023
Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United StatesWentao Tian, Lishui Niu, Ziqi Wang, et al.
Medcomm|December 23, 2024
Metastatic brain tumors: from development to cutting-edge treatmentGuilong Tanzhu, Liu Chen, Jiaoyang Ning, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2025
Predicting Survival Rates in Brain Metastases Patients from Non-Small Cell Lung Cancer Using Radiomic Signatures Associated with Tumor Immune HeterogeneityFuxing Deng, Gang Xiao, Guilong Tanzhu, et al.
Pageof 2